glp 1 drugs non prescription GLP-1 use tripled among non-diabetics, reaching $5.8B in 2022 Market Overview: GLP-1 Agonists and

non-neurons using canonical marker genes (e.g., Slc17a6, Slc32a1, Snap25, Syp etc.) for neurons, Mag for oligodendrocytes, Ntsr2 for astrocytes)

When neurological symptoms are present, more intensive treatment is required: 1 mg hydroxocobalamin on alternate days until no further improvement occurs, followed by maintenance therapy every two months

LaBerges patent [28] shows that AChEIs, such as galantamine, donepezil, rivastigmine, and huperzine A, significantly increase the clarity of cognition, lucidity, self-reflection, recall, control, bizarreness, and visual vividness, with few side effects

10.1016/j.bbapap.2014.04.016 Biochim

What is the ideal glutathione dosage per day